MC4R (melanocortin 4 receptor) is a key regulator of energy homeostasis and appetite. Loss-of-function mutations are strongly linked to early-onset obesity, but the direct evidence for fatigue is limited. Fatigue may arise secondarily from obesity-related conditions such as sleep apnea, metabolic syndrome, or low-grade inflammation, which can be influenced by MC4R variants. Human observational studies and GWAS show associations with BMI and energy expenditure, but fatigue is not a primary endpoint. The evidence is moderate: MC4R's role in fatigue is indirect and context-dependent. Consumer DNA tests often overstate the link, marketing MC4R as a 'fatigue gene' without robust clinical validation. Effect sizes are small, and lifestyle factors (sleep, stress, nutrition) are far more impactful. A single gene test cannot diagnose or explain chronic fatigue. Clinical evaluation should consider multifactorial causes. Therefore, while MC4R is biologically plausible, its practical utility for fatigue management is currently low.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-19b530450168bddc70ba02f5